Lenalidomide in combination with dexamethasone improves survival and time-to-progression in patients ≧65 years old with relapsed or refractory multiple myeloma
スポンサーリンク
概要
- 論文の詳細を見る
- 2012-08-01
著者
-
CHANAN-KHAN Asher
Department of Medicine, Roswell Park Cancer Institute Buffalo
-
LONIAL Sagar
Emory Winship Cancer Institute
-
WEBER Donna
M. D. Anderson Cancer Center
-
BORRELLO Ivan
The Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
-
FOA Robin
Department of Cellular Biotechnologies and Hematology, Sapienza University of Rome
-
HELLMANN Andrzej
Department of Hematology and Transplantology, Medical University of Gdansk
-
DIMOPOULOS Meletios
The University of Athens School of Medicine
-
SWERN Arlene
Celgene Corporation
-
KNIGHT Robert
Celgene Corporation